{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:53:37Z","timestamp":1791579217975,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["15102"],"award-info":[{"award-number":["15102"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.retram.2026.103613","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:40Z","timestamp":1790724100000},"page":"103613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line"],"prefix":"10.1016","volume":"74","author":[{"given":"Atefeh Habibi","family":"Asl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Valadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Taghiloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Joudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Zaboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Darvishkhezri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolghasem","family":"Ajami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0001","first-page":"1","article-title":"Progress and challenges in survivorship after acute myeloid leukemia","volume":"16","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.retram.2026.103613_bib0002","first-page":"1","article-title":"Understanding quality of life in patients with acute leukemia: a global perspective","volume":"37","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0003","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12938-025-01403-7","article-title":"Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: findings from the global burden of disease study 2021","volume":"24","author":"Han","year":"2025","journal-title":"BioMedical Engineering OnLine"},{"issue":"12","key":"10.1016\/j.retram.2026.103613_bib0004","first-page":"1345","article-title":"The 5th edition of the World Health Organization Classification of Hematologic Malignancies","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2026.103613_bib0005","first-page":"12","article-title":"Treatment of relapsed acute lymphoblastic leukemia (ALL) in adult patients","volume":"25","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"18","key":"10.1016\/j.retram.2026.103613_bib0006","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.3390\/cancers15184550","article-title":"Bispecific antibodies in hematological malignancies: A scoping review","volume":"15","author":"Neelapu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2026.103613_bib0007","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1186\/s12967-024-05768-6","article-title":"CD38 as theranostic target in oncology","volume":"22","author":"Bocuzzi","year":"2024","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.retram.2026.103613_bib0008","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2052658","article-title":"Anti-CD38 monoclonal antibodies for multiple myeloma treatment","volume":"18","author":"Gozzetti","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"10.1016\/j.retram.2026.103613_bib0009","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1182\/bloodadvances.2022007059","article-title":"CD38 as a pan-hematologic target for chimeric antigen receptor T cells","volume":"7","author":"Glisovic-Aplenc","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.retram.2026.103613_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40262-023-01240-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of daratumumab","volume":"62","author":"Kim","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.retram.2026.103613_bib0011","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12967-023-04210-7","article-title":"Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH","volume":"21","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/toxins14010063","article-title":"Toxin and immunotoxin based therapeutic approaches","volume":"14","author":"Bortolotti","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0013","first-page":"1234","article-title":"EGFR-targeting RNase A\u2013cetuximab antibody\u2013drug conjugate induces apoptosis in KRAS mutant colorectal cancer cells","volume":"15","author":"Newton","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.retram.2026.103613_bib0014","series-title":"Edible Medicinal and Non Medicinal Plants. Volume 8: Flowers","first-page":"489","article-title":"Bougainvillea spectabilis","author":"Lim","year":"2014"},{"issue":"6","key":"10.1016\/j.retram.2026.103613_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/toxins3060697","article-title":"Immunotoxins and other conjugates containing ribosome-inactivating proteins for cancer therapy","volume":"3","author":"Polito","year":"2011","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.retram.2026.103613_bib0016","first-page":"574","article-title":"Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganin","volume":"32","author":"Cizeau","year":"2009","journal-title":"Journal of immunotherapy (Hagerstown, Md: 1997)"},{"key":"10.1016\/j.retram.2026.103613_bib0017","article-title":"Conditioned activation of immunotoxins with prolonged half-life can enhance antitumor efficacy","volume":"239","author":"Wang","year":"2024","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.retram.2026.103613_bib0018","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3324\/haematol.2015.137620","article-title":"Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma","volume":"101","author":"Drent","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2026.103613_bib0019","article-title":"Bacteria-derived chimeric toxins as potential anticancer agents","volume":"12","author":"Kaplan","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0020","first-page":"3","article-title":"The BCL-2 protein family: from discovery to drug development","volume":"32","author":"Strasser","year":"2025","journal-title":"Cell Death Differ"},{"issue":"17","key":"10.1016\/j.retram.2026.103613_bib0021","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/cells13171463","article-title":"Inhibition of STAT3 phosphorylation by TTI-101 and SH5-07 suppresses proliferation and induces apoptosis in bladder cancer cells","volume":"13","author":"Alshehri","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.retram.2026.103613_bib0022","first-page":"1171","article-title":"CD38-directed chimeric antigen receptor (CAR) T-cell therapy: a new avenue for the treatment of lymphoid malignancies?","volume":"101","author":"Drent","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0023","first-page":"70","article-title":"Bouganin-based immunotoxin engineering and targeting of CD38 in non-Hodgkin\u2019s lymphoma","volume":"32","author":"Cizeau","year":"2009","journal-title":"Journal of Immunotherapy"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0024","first-page":"1","article-title":"CD38 as a Theranostic Target in Oncology","volume":"22","author":"Bocuzzi","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.retram.2026.103613_bib0025","article-title":"Isatuximab in acute myeloid leukemia: mechanisms and clinical applications","volume":"13","author":"Bahlis","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0026","first-page":"1","article-title":"Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism","volume":"17","author":"Huang","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.retram.2026.103613_bib0027","first-page":"1","article-title":"Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism","volume":"17","author":"Huang","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.retram.2026.103613_bib0028","first-page":"164","article-title":"Preclinical evaluation of VB6-845: an anti-EpCAM immunotoxin with engineered low immunogenicity","volume":"5","author":"McCormick","year":"2012","journal-title":"Cell Mol Bioeng"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:40:43Z","timestamp":1791578443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2452318626000498"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103613","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103613"}}